The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

Por Abou El Hassan, M A I, Verheul, H M W, Jorna, A S, Schalkwijk, C, van Bezu, J, van der Vijgh, W J F, Bast, A
Publicado em 2003

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina

Por Hughes, J. M., Kuiper, E. J., Klaassen, I., Canning, P., Stitt, A. W., Van Bezu, J., Schalkwijk, C. G., Van Noorden, C. J. F., Schlingemann, R. O.
Publicado em 2007

A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity

Por Amado-Azevedo, J., Reinhard, N. R., van Bezu, J., de Menezes, R. X., van Beusechem, V. W., van Nieuw Amerongen, G. P., van Hinsbergh, V. W. M., Hordijk, P. L.
Publicado no Sci Rep (2017)